Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Thomas Malley


  • Director at Kura Oncology Inc. (KURA), 2019-06-27
  • Director at Beigene Ltd. (BGNE), 2019-06-07
  • Director at Kiniksa Pharmaceuticals Ltd. (KNSA), 2019-05-30
  • Director at Ovascience Inc. (OVAS), 2017-07-05
  • Director at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Director at Puma Biotechnology Inc. (PBYI), 2014-12-17
  • Director at Cougar Biotechnology Inc. (CGRB), 2009-07-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BGNE $32.00 30,000 Director 30,000 2016-11-23 Filing
KURA $8.00 50,000 Director 89,557 2015-11-10 Filing
OVAS $28.50 5,000 Director 122,200 2015-04-08 Filing
OVAS $50.00 35,000 Director 116,819 2015-01-13 Filing
OVSC $9.00 50,000 Director 81,819 2013-03-18 Filing